# Beckman-Diagnostic Systems Group

- Location (FDA's records): Brea, CA
- FDA decisions: 11 (1993–1994): 11 510(k) clearances
- Product codes: LCM (1), DFT (1), CHH (1), DKC (1), JFJ (1), CIG (1), KHP (1), DKZ (1), JJY (1), JJF (1), DJG (1)
- Predicates its devices cite: 0 (0 its own); citations of its devices by later devices: 13 (0 its own)
- Recalls linked to its devices: 1 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms that cite its devices most
- Diamond Diagnostics, Inc.: 4 (https://510kreport.com/company/diamond-diagnostics)
- Beckman Instruments, Inc.: 4 (https://510kreport.com/company/beckman-instruments)
- Beckman Coulter, Inc.: 3 (https://510kreport.com/company/beckman-coulter)
- Biosafe Laboratories, Inc.: 2 (https://510kreport.com/company/biosafe-laboratories)

## Its most-cited devices
- K942676: Synchron CX3 Delta (1994), cited by 5
- K934046: Beckman Cholesterol Reagent (1993), cited by 3
- K936184: Vigil PRX Chemistry Control (1994), cited by 3
- K934293: Beckman Pancreatic Amylase (Pamy) Reagent (1994), cited by 1
- K944606: CX Opiate Reagent for Synchron CX Systems (1994), cited by 1

## Recent decisions
- K945522: I.D.-Zone Immunofixation Electrophoresis Controls (Dec 12, 1994)
- K944605: CX Phencyclidine Reagent  for Synschron CX System (Dec 7, 1994)
- K944604: CX Amphetamines Reagent for Synchron CX Systems (Dec 7, 1994)
- K944606: CX Opiate Reagent for Synchron CX Systems (Nov 30, 1994)
- K942676: Synchron CX3 Delta (Nov 2, 1994)
- K934293: Beckman Pancreatic Amylase (Pamy) Reagent (Jul 6, 1994)
- K934068: Beckman Direct Bilirubin Reagent (Apr 26, 1994)
- K936184: Vigil PRX Chemistry Control (Apr 15, 1994)

Source page: https://510kreport.com/company/beckman-diagnostic-systems-group